DNA sequencing and genetic testing is nothing new, but BillionToOne is taking it one step further performing molecular diagnostics at an incredibly specific level. One of their products, UNITY Fetal Risk Screen, accurately assesses fetal risk for common autosomal recessive conditions without requiring a blood sample from the male partner...that was 96% sensitive for identifying a fetus as high risk across a sample size of over 40,000 patients. Early identification is key for disease management, and by being able to provide direct fetal insights into prevalent autosomal recessive conditions such as Cystic Fibrosis, Spinal Muscular Atrophy, and Alpha and Beta Hemoglobinopathies (including Sickle Cell Disease), more time for better clinical decisioning can occur. Science is amazing. (November 2023)